Psychedelic Business Spotlight – May 27
This week in psychedelic business news: New patents; another Health Canada SAP Approval; and legal psilocybin rules for Oregon.
Greg Gilman is Psychedelic Spotlight's lead content editor, as well as a contributor. His previous work has appeared in dozens of publications, including USA Today, Yahoo! News, TheWrap, MovieMaker Magazine and SyFy Wire. When he's not writing, he's the lead singer for LA-based Americana rock band Greg in Good Company. Given his experience as an artist, he's particularly interested in the intersection of psychedelics and entertainment.
This week in psychedelic business news: New patents; another Health Canada SAP Approval; and legal psilocybin rules for Oregon.
This week in psychedelic business news: Another psychedelic merger; an Optimi Health acquisition; and good news for alcohol abuse treatment.
I finally caught the bug, and after a mild bout with the Coronavirus, I ate 3.7 grams of mushrooms during my final weekend of quarantine.
This week in psychedelic business news: Beckley Retreats set launch; another shark swims into the psychedelics industry; and MindMed shares promising LSD study results.
This week in psychedelic business news: Wesana Health pivots strategy; Compass Pathways makes progress on anorexia; Completion launches psychedelic VR NFTs.
There is currently no FDA-approved treatment for anorexia. Could psychedelics be the answer?
This week in psychedelic business news: Field Trip Health splits in two, Tryp Therapeutics commences study, and Optimi Health celebrates new facility.
Watch late psychedelic icons María Sabina and Terence McKenna in action, and catch a glimpse inside psilocybin therapy sessions.
Famed film composer returns to rock roots for a masterful, mind-melting Coachella set, and I was fortunate to catch it while tripping on LSD.
This week in psychedelic business news: Mindset Pharma files a new patent; Ehave's MetaHealthU app seeks to cure HPPD; Wellbeing Digital Sciences contemplates a sale.
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.